OpenVSafe by OpenVAERS
Search V-safe

EM3-26572-22900

3 vaccinations 4 coded responses 15 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
467 / IN
Registered
2022-01-03
Relationship
Adult relative or friend
Guardian
9WX-26030-66677
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-12-29
    Dose 1 — Pfizer-BioNTech
  2. 2022-01-03
    Registered in v-safe
  3. 2022-01-03
    Survey response — days 1–6 daily, dose 1, dependent
    MedDRA: Pre-existing disease — Feeling: Good
    Free text: Health History: High blood pressure, Afib, high cholesterol, Osteogenesis Imperfecta, Melanoma surgery
    MedDRA releases: 2024-11 · check-in free text available
  4. 2022-01-05
    Health check-in — day 7, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  5. 2022-01-15
    Health check-in — day 14, dose 1, dependent
    Feeling: Good
    Adult check-in
  6. 2022-01-19
    Health check-in — day 21, dose 1, dependent
    Feeling: Good
    Adult check-in
  7. 2022-01-29
    Health check-in — day 28, dose 1, dependent
    Feeling: Good
    Adult check-in
  8. 2022-01-31
    Dose 2 — Pfizer-BioNTech
  9. 2022-02-02
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  10. 2022-02-03
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tiredness
    Adult check-in
  11. 2022-02-06
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Site: Redness, Swelling · None
    Adult check-in
  12. 2022-02-07
    Health check-in — day 7, dose 2, dependent
    Feeling: Good · Site: Redness · None
    Adult check-in
  13. 2022-02-14
    Health check-in — day 14, dose 2, dependent
    Feeling: Good
    Adult check-in
  14. 2022-02-25
    Survey response — day 21, dose 2, dependent
    MedDRA: Joint swelling, Peripheral swelling — Feeling: Good
    Free text: Swollen ankles-calves
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-03-12
    Survey response — day 35, dose 2, dependent
    MedDRA: Joint swelling — Feeling: Good
    Free text: Swollen ankles
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-03-16
    Health check-in — day 42, dose 2, dependent
    Feeling: Good
    Adult check-in
  17. 2022-05-02
    Survey response — 3 months, dose 2, dependent
    MedDRA: Joint swelling — Feeling: Good
    Free text: Puffy ankles
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-06-30
    Dose 3 — Pfizer-BioNTech
  19. 2022-07-06
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-12-29Pfizer-BioNTech No
22022-01-31Pfizer-BioNTech No
32022-06-30Pfizer-BioNTech No

Free text

Release 10 — days 1–6 daily, dose 1, dependent

2022-01-03

Systemic reaction (other): Health History: High blood pressure, Afib, high cholesterol, Osteogenesis Imperfecta, Melanoma surgery

Release 11 — day 21, dose 2, dependent

2022-02-25

Symptoms: Swollen ankles-calves

Release 11 — day 35, dose 2, dependent

2022-03-12

Symptoms: Swollen ankles

Release 11 — 3 months, dose 2, dependent

2022-05-02

Symptoms: Puffy ankles

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDJoint swelling · · ✓
SDPeripheral swelling · · ✓
SROPre-existing disease · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release